Strategically, this acquisition allows the leading global provider of traceability systems for the pharmaceutical and medical device industries to not only complete its traceability offering and provide end-to-end solutions, but also expand its portfolio to cater to a wide range of diverse industries.
“Our plan is to optimize supply chains to increase our customers' performance while at the same time building a sustainable economy in the long term,” says Louis Roy, President of OPTEL GROUP. “This acquisition allows us to quickly attain a crucial part of that goal, which is to connect the supply chain.”
The acquisition combines OPTEL's experience in deploying characterization and data-capturing solutions in industrial environments with Verify Brand's proven data management and analytics expertise.
The addition of Verify Brand's L4/5 serialization capabilities to the OPTEL solution set enables the connectivity required for pharma companies to implement track and trace throughout the entire supply chain (L1 toL5).
"With increased global regulations and consumer demand for greater transparency, brands need solutions that deliver true end-to-end supply chain visibility,” says Michael Howe, CEO of Verify Brand. “Combining our mature, flexible serialization platform with OPTEL s Track & Trace capabilities will open up access to the data, analytics and reports that brands need to finally enable this visibility. We believe the innovations we can deliver will create solutions that meet the demands of brands both today, and into the future."
OPTEL has always used artificial intelligence in its automated solutions. This capability can now be used to automatically analyze the big data that is generated throughout the supply chain and allow customers to transition into the fourth industrial revolution, or the digitization of manufacturing. OPTEL 's solutions will provide ultimate business intelligence to optimize processes and build greater proximity to suppliers and customers.
OPTEL aims to solve difficult problems for its customers, and the acquisition of Verify Brand provides access to the innovative technologies to do exactly that.
These solutions provide the opportunity for OPTEL to develop a cross-functional platform with the potential to serve industries beyond life sciences.